Related Experiment Video
Updated: Jan 10, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Cavin-3 promotes TNF expression via the MAPK signaling pathway in lung squamous cell carcinoma
Xiaoyan Xu1, Yonghong Nie2, Jiatuo Xu1
1School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Abstract:
Cavin family proteins alter the invasiveness of tumor cells. However, research on the pathogenesis of Cavins in tumors is lacking. To address this knowledge-gap, we conducted a systematic analysis about the mechanism of action of Cavins in cancer. We evaluated the diagnostic value of Cavin-3 and its potential as a new therapeutic target for lung squamous cell carcinoma (LUSC). Bioinformatic analysis showed that Cavin-3 can inhibit LUSC tumor cells by regulating the expression of EREG and IL1A, thereby activating the MAPK pathway to promote the release of tumor necrosis factor (TNF) and other inflammatory factors. Moreover, in vitro experiments have shown that Cavin-3 may promote the expression of inflammatory factors by regulating the MAPK signaling pathway, thereby killing tumor cells and inhibiting tumor proliferation.
Insights
Cavin-3 protein inhibits lung squamous cell carcinoma (LUSC) progression by regulating inflammatory factors via the MAPK pathway. This finding highlights Cavin-3 as a potential diagnostic marker and therapeutic target for LUSC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cavin family proteins influence tumor cell invasiveness.
- Limited research exists on the specific role and mechanisms of Cavins in cancer pathogenesis.
- A knowledge gap necessitates a detailed investigation into Cavin proteins' functions in tumorigenesis.
Purpose of the Study:
- To systematically analyze the mechanism of action of Cavins in cancer.
- To evaluate Cavin-3's diagnostic value in lung squamous cell carcinoma (LUSC).
- To explore Cavin-3 as a potential therapeutic target for LUSC.
Main Methods:
- Bioinformatic analysis to identify molecular mechanisms.
- In vitro experiments to validate biological functions.
- Assessment of Cavin-3 expression and its correlation with LUSC progression.
Main Results:
- Cavin-3 was found to inhibit LUSC tumor cells.
- Cavin-3 regulates EREG and IL1A expression, activating the MAPK pathway.
- Activation of MAPK pathway promotes the release of tumor necrosis factor (TNF) and inflammatory factors, inhibiting tumor proliferation.
Conclusions:
- Cavin-3 plays a significant role in inhibiting LUSC progression.
- Cavin-3 acts by modulating the MAPK signaling pathway and inflammatory responses.
- Cavin-3 presents potential as a diagnostic biomarker and therapeutic target for LUSC.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
08:54Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
Related Concept Videos
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways